long-term efficacy of daratumumab-based regimen in multiple myeloma
Published 1 year ago • 478 plays • Length 7:32Download video MP4
Download video MP3
Similar videos
-
6:20
5-year data supports efficacy and safety of daratumumab as add-on therapy for multiple myeloma
-
3:15
patient reported outcomes supports addition of daratumumab in multiple myeloma treatment
-
5:16
efficacy of daratumumab in multiple myeloma
-
1:57
dr. shah on daratumumab-based regimens in frontline multiple myeloma
-
4:03
maia and alcyone: follow-up of daratumumab in multiple myeloma
-
11:08
real data on efficacy of transitioning to ixazomib-based treatment for multiple myeloma
-
1:44
trimm-2: talquetamab daratumumab in patients with r/r multiple myeloma
-
4:56
treatment benefit of daratumumab for multiple myeloma supported by 3-year follow-up data
-
5:03
daratumumab pomalidomide & dexamethasone effective in relapsed/refractory multiple myeloma
-
3:39
efficacy and tolerability of ixazomib, daratumumab and low dose dex in unfit and frail ndmm patients
-
1:22
daratumumab and dexamethasone in the treatment of patients with myeloma and severe renal impairment
-
4:01
choosing between isatuximab & daratumumab in multiple myeloma
-
3:05
sc daratumumab plus standard-of-care regimens in myeloma
-
5:28
daratumumab with ixazomib and dex in pts with one prior lenalidomide-based regimen: the daria study
-
4:23
ifm 2018-02: ixazomib daratumumab in elderly frail patients with r/r multiple myeloma
-
4:17
evaluating the safety and efficacy of elranatamab in multiple myeloma
-
1:45
real-world safety & efficacy of isatuximab-pomalidomide-dexamethasone in r/r multiple myeloma
-
1:11
dr. jacob laubach on the efficacy of daratumumab in myeloma
-
2:59
exploring the potential role of melflufen in myeloma & updates from the lighthouse trial